Skip to main content
Premium Trial:

Request an Annual Quote

Vysis Expands Genetic Workstations Sales

Premium

DOWNERS GROVE, Ill.--Vysis, a genomic disease management company here specializing in clinical products for evaluating and managing cancer, prenatal disorders, and other genetic diseases, signed agreements in February that will broaden its worldwide coverage to include Mexico, Brazil, and Southern Africa and expand its distributor relationship in Spain. Vysis CEO John Bishop said the company will continue to add distributors to make its clinical and research products and genetic workstations available to clinical labs around the world.

In Mexico and Brazil, Omnichem of Mexico City will distribute Vysis products. In Southern Africa, BDS Diagnostics of Pretoria, South Africa, will handle distribution. Spanish distributor Isaza of Barcelona will market one of Vysis's first clinically approved prenatal products for the early detection of genetic abnormalities associated with mental retardation and other birth defects. Vysis genetic workstations utilize proprietary Fluorescence In Situ Hybridization (FISH) test platforms.

Filed under

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.